Inside the Cetuximab Biosimilar Market: Clinical Innovation, Competition, and Growth
The rising prevalence of colorectal cancer and head and neck cancer, increasing demand for cost-effective biologic therapies, and the growing adoption of biosimilars are driving the growth of the Cetuximab Biosimilar Market. However, the market also faces several challenges. Stringent regulatory approval pathways, high development and manufacturing costs, complex clinical comparability...
0 Reacties 0 aandelen 19 Views 0 voorbeeld